Lexaria Bioscience
Yahoo Finance • 16 days ago
Lexaria Bioscience stock soars after ending $5M stock sale agreement with JonesTrading
* Lexaria Bioscience (NASDAQ:LEXX [https://seekingalpha.com/symbol/LEXX]) rose 32% in premarket trading on Friday after the company announced [https://www.sec.gov/Archives/edgar/data/1348362/000164033425001717/lxrp_8k.htm] the terminatio... Full story
Yahoo Finance • 16 days ago
Mixed Catalysts Drive After-Hours Moves In MRM, LEXX, SHOT, AQST, And OVID
(RTTNews) - Several small-cap names posted sharp gains in Thursday's after-hours session, driven by fresh corporate updates, clinical developments, and strategic pivots. Below are five stocks that stood out for their notable post-close mov... Full story
Yahoo Finance • 2 months ago
GLP-1 "Arms Race" Broadens to Include Dozens of Companies
Lexaria highlights DehydraTECH's adverse events improvement opportunity KELOWNA, BC / ACCESS Newswire / August 6, 2025 / Lexaria Bioscience Corp. (Nasdaq:LEXX)(Nasdaq:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug deliver... Full story
Yahoo Finance • 3 months ago
Lexaria Bioscience stock price target lowered to $5 at H.C. Wainwright
Investing.com - H.C. Wainwright lowered its price target on Lexaria Bioscience (NASDAQ:LEXX) to $5.00 from $7.00 on Tuesday, while maintaining a Buy rating on the stock. The revision comes as LEXX trades near its 52-week low of $0.82, ha... Full story
Yahoo Finance • 2 years ago
Lexaria Bioscience Corp. (NASDAQ: LEXX) Evaluating Proprietary Drug-Delivery Platform for Improved Efficacy of GLP-1 Drugs
NEW YORK, Oct. 31, 2023 (GLOBE NEWSWIRE) -- via InvestorWire — Lexaria Bioscience Corp. (NASDAQ: LEXX) today announces its placement in an editorial published by NetworkNewsWire ("NNW"), one of 60+ brands within the Dynamic Brand Portfol... Full story
Yahoo Finance • 3 years ago
Lexaria Bioscience Corp. (NASDAQ: LEXX) Focused on Filling Need for Hypertension Treatment Solution
NEW YORK, Aug. 11, 2022 (GLOBE NEWSWIRE) -- NetworkNewsAudio – Lexaria Bioscience Corp. (NASDAQ: LEXX) announces the availability of a broadcast titled, “The Power of Science to Stop a Killer.” To hear the AudioPressRelease, please visi... Full story
Yahoo Finance • 3 years ago
Lexaria Bioscience Corp. (NASDAQ: LEXX) Stands as Global Leader in Delivery Tech Space
NEW YORK, May 26, 2022 (GLOBE NEWSWIRE) -- NetworkNewsAudio – Lexaria Bioscience Corp. (NASDAQ: LEXX) announces the availability of a broadcast titled, “Nicotine Surges as Smoking Sags.” To hear the AudioPressRelease, please visit: The... Full story
Yahoo Finance • 3 years ago
Lexaria Bioscience Corp. (NASDAQ: LEXX) Offers Breakthrough Delivery Tech in Hot Nicotine Space
NEW YORK, May 25, 2022 (GLOBE NEWSWIRE) -- via InvestorWire — Lexaria Bioscience Corp. (NASDAQ: LEXX) today announces its placement in an editorial published by NetworkNewsWire ("NNW"), one of 50+ trusted brands within the InvestorBrandN... Full story
